Malaysia vs Palestine: Cause of death, by non-communicable diseases, female
Malaysia
69.2%
in 2021
Palestine
69.2%
in 2021
Malaysia rank
90th
Palestine rank
91st
Cause of death, by non-communicable diseases, female over time
- Malaysia
- Palestine
How they compare
Malaysia currently reports 69.2% against 69.2% in Palestine, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Malaysia ahead.
Malaysia ranks 90th and Palestine ranks 91st of 185 countries.
Across the 3 decades both report, Malaysia averaged higher in 2 and Palestine in 1.
Head to head by decade
| Decade | Malaysia | Palestine | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.9% | 64.2% | 15.7% | Malaysia |
| 2010s | 79.5% | 80.3% | 0.8% | Palestine |
| 2020s | 74.8% | 73.2% | 1.6% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Malaysia or Palestine?
- Malaysia, at 69.2% against 69.2% in Palestine as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Malaysia and Palestine?
- 0.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Palestine?
- 6 years are reported by both, from 2000 to 2021.
- How do Malaysia and Palestine rank globally for cause of death, by non-communicable diseases, female?
- Malaysia ranks 90th and Palestine ranks 91st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.